6 completed, 1 recruiting, 1 withdrawn. 4 Phase 2, 3 Phase 3, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 3 | 3 | Completed 3 |
| Early Phase 1 | 1 | Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow CDB-2914: new trials by email Literature Review of CDB-2914 trials Research Report on CDB-2914
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mammogram Pretreatment With Ulipristal Acetate Biospecimen Collection, Magnetic Resonance Imaging, Mammogram - Mammography Screening, Breast Density | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 26 | 2026-08-21 | 2026-09-03 |
| CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women CDB-2914 - Urogenital Abnormalities | Early Phase 1 | Withdrawn | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2011-11-08 | 2019-12-17 | |
| Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914 CDB-2914 - Contraception | Phase 2 | Completed | Population Council | 55 | 2008-10-01 | 2017-08-15 |
| Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception CDB-2914, Levonorgestrel - Contraception | Phase 3 | Completed | HRA Pharma | 2221 | 2007-04-01 | 2022-05-03 |
| Safety and Efficacy of CDB-2914 for Emergency Contraception CDB-2914 - Emergency Contraception | Phase 3 | Completed | HRA Pharma | 1623 | 2006-11-01 | 2021-09-21 |
| Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist CDB-2914 - Leiomyoma | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 56 | 2002-09-02 | 2019-12-17 |
| Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914 CDB-2914, COB-2914 - Healthy | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 15 | 2002-05-01 | 2008-03-04 |
| Efficacy Trial of CDB 2914 for Emergency Contraception CDB-2914, levonorgestrel - Emergency Contraception | Phase 2 / Phase 3 | Completed | University of Pittsburgh | 1672 | 1999-09-01 | 2007-12-17 |
Leiomyoma (1) · Metrorrhagia (1) · Myofibroma (1) · Urogenital Abnormalities (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3) · HRA Pharma (2) · OHSU Knight Cancer Institute (1) · Population Council (1) · University of Pittsburgh (1)
United States (7) · Chile (1) · Dominican Republic (1) · Ireland (1) · United Kingdom (1)
Abigail Liberty (1) · Alicia Y Christy, M.D. (1) · Anna F Glasier, MD (1) · Diana Blithe, PhD (1) · Lynnette K Nieman, M.D. (1) · Paul Fine, MD (1)